Pour la première fois, un vaccin thérapeutique - contre le mélanome - semble efficace pour réduire les risques de récidive. Une annonce porteuse d’espoir, mais qui pose encore, à ce stade, de nombreuses questions.

News of first positive large late-stage trial result for drug could signal new era for treating solid-tumor cancers, with tests underway for lung, breast and pancreatic cancers

Merck and Moderna report that a personalized mRNA vaccine helped prevent skin cancer from returning in high-risk patients. Observers greeted the news with enthusiasm but noted…

Moderna e MSD anunciam resultados promissores do imunizante nesta quarta

Merck and Moderna’s personalized mRNA cancer vaccine helps prevent melanoma recurrence and spread, raising hopes for use against other cancers.